Compass Rose Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$31.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$36.5M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$34.3M |
| 3 |
Ford
F
|
+$9.94M |
| 4 |
General Motors
GM
|
+$9.89M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$6.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 78.53% |
| 2 | Healthcare | 21.47% |
| 3 | Communication Services | 0% |
| 4 | Consumer Discretionary | 0% |
Similar funds
Compass Rose Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Compass Rose Asset Management held 12 positions worth $239M, up 37% from $174M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Compass Rose Asset Management withdrew a net $43.9M in Q4 2023, closing 7 positions and reducing 1 holding. Its most notable exit was Verizon, an estimated $36.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 68% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Compass Rose Asset Management opened a new position in Pfizer worth $29.8M.
- Compass Rose Asset Management's largest Q4 2023 buy was Pfizer: 1,035,000 shares worth $29.8M.
- Compass Rose Asset Management's biggest Q4 2023 reduction was iShares China Large-Cap ETF, cutting an estimated $6.56M.
- Compass Rose Asset Management fully exited Verizon in Q4 2023, selling an estimated $36.5M.
- Compass Rose Asset Management's ten largest holdings make up 100% of its $239M portfolio in Q4 2023.
- Compass Rose Asset Management opened 4 new positions and closed 7 in Q4 2023.
- Compass Rose Asset Management's portfolio value rose 37% quarter-over-quarter to $239M.
Based on Compass Rose Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.